vs
Side-by-side financial comparison of OLIN Corp (OLN) and Roper Technologies (ROP). Click either name above to swap in a different company.
Roper Technologies is the larger business by last-quarter revenue ($2.1B vs $1.7B, roughly 1.3× OLIN Corp). Roper Technologies runs the higher net margin — 15.8% vs -8.6%, a 24.4% gap on every dollar of revenue. On growth, Roper Technologies posted the faster year-over-year revenue change (11.3% vs -0.4%). Over the past eight quarters, Roper Technologies's revenue compounded faster (10.5% CAGR vs 0.9%).
Olin Corporation is an American manufacturer of ammunition, chlorine, and sodium hydroxide. The company traces its roots to two companies, both founded in 1892: Franklin W. Olin's Equitable Powder Company and the Mathieson Alkali Works. Accidents at Olin chemical plants have exposed employees and nearby residents to health hazards.
Roper Technologies, Inc. is a holding company that owns companies in the technology sector.
OLN vs ROP — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.7B | $2.1B |
| Net Profit | $-143.2M | $331.0M |
| Gross Margin | 1.9% | 69.4% |
| Operating Margin | -9.4% | 27.2% |
| Net Margin | -8.6% | 15.8% |
| Revenue YoY | -0.4% | 11.3% |
| Net Profit YoY | -1517.8% | 53.7% |
| EPS (diluted) | $-1.25 | $4.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $2.1B | ||
| Q4 25 | $1.7B | $2.1B | ||
| Q3 25 | $1.7B | $2.0B | ||
| Q2 25 | $1.8B | $1.9B | ||
| Q1 25 | $1.6B | $1.9B | ||
| Q4 24 | $1.7B | $1.9B | ||
| Q3 24 | $1.6B | $1.8B | ||
| Q2 24 | $1.6B | $1.7B |
| Q1 26 | — | $331.0M | ||
| Q4 25 | $-143.2M | $428.4M | ||
| Q3 25 | $43.7M | $398.5M | ||
| Q2 25 | $-2.8M | $378.3M | ||
| Q1 25 | $1.2M | $331.1M | ||
| Q4 24 | $10.1M | $462.3M | ||
| Q3 24 | $-25.2M | $367.9M | ||
| Q2 24 | $72.3M | $337.1M |
| Q1 26 | — | 69.4% | ||
| Q4 25 | 1.9% | 69.5% | ||
| Q3 25 | 10.7% | 69.5% | ||
| Q2 25 | 7.9% | 69.2% | ||
| Q1 25 | 9.0% | 68.7% | ||
| Q4 24 | 9.4% | 68.3% | ||
| Q3 24 | 8.5% | 69.2% | ||
| Q2 24 | 14.5% | 69.5% |
| Q1 26 | — | 27.2% | ||
| Q4 25 | -9.4% | 28.6% | ||
| Q3 25 | 4.8% | 28.4% | ||
| Q2 25 | 2.0% | 28.2% | ||
| Q1 25 | 2.7% | 27.9% | ||
| Q4 24 | 2.8% | 28.0% | ||
| Q3 24 | 1.0% | 28.1% | ||
| Q2 24 | 8.3% | 28.8% |
| Q1 26 | — | 15.8% | ||
| Q4 25 | -8.6% | 20.8% | ||
| Q3 25 | 2.6% | 19.8% | ||
| Q2 25 | -0.2% | 19.5% | ||
| Q1 25 | 0.1% | 17.6% | ||
| Q4 24 | 0.6% | 24.6% | ||
| Q3 24 | -1.6% | 20.8% | ||
| Q2 24 | 4.4% | 19.6% |
| Q1 26 | — | $4.87 | ||
| Q4 25 | $-1.25 | $3.97 | ||
| Q3 25 | $0.37 | $3.68 | ||
| Q2 25 | $-0.01 | $3.49 | ||
| Q1 25 | $0.01 | $3.06 | ||
| Q4 24 | $0.10 | $4.29 | ||
| Q3 24 | $-0.21 | $3.40 | ||
| Q2 24 | $0.62 | $3.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.6M | $382.9M |
| Total DebtLower is stronger | $2.8B | $9.7B |
| Stockholders' EquityBook value | $1.8B | $18.8B |
| Total Assets | $7.3B | $34.6B |
| Debt / EquityLower = less leverage | 1.55× | 0.52× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $382.9M | ||
| Q4 25 | $167.6M | $297.4M | ||
| Q3 25 | — | $320.0M | ||
| Q2 25 | — | $242.4M | ||
| Q1 25 | — | $372.8M | ||
| Q4 24 | $175.6M | $188.2M | ||
| Q3 24 | — | $269.6M | ||
| Q2 24 | — | $251.5M |
| Q1 26 | — | $9.7B | ||
| Q4 25 | $2.8B | $9.3B | ||
| Q3 25 | $3.0B | — | ||
| Q2 25 | $3.0B | — | ||
| Q1 25 | $3.0B | — | ||
| Q4 24 | $2.7B | $7.6B | ||
| Q3 24 | $2.8B | — | ||
| Q2 24 | $2.8B | — |
| Q1 26 | — | $18.8B | ||
| Q4 25 | $1.8B | $19.9B | ||
| Q3 25 | $2.0B | $20.0B | ||
| Q2 25 | $2.0B | $19.6B | ||
| Q1 25 | $2.0B | $19.2B | ||
| Q4 24 | $2.0B | $18.9B | ||
| Q3 24 | $2.1B | $18.5B | ||
| Q2 24 | $2.1B | $18.1B |
| Q1 26 | — | $34.6B | ||
| Q4 25 | $7.3B | $34.6B | ||
| Q3 25 | $7.6B | $34.6B | ||
| Q2 25 | $7.7B | $33.2B | ||
| Q1 25 | $7.7B | $31.4B | ||
| Q4 24 | $7.6B | $31.3B | ||
| Q3 24 | $7.5B | $31.6B | ||
| Q2 24 | $7.7B | $29.8B |
| Q1 26 | — | 0.52× | ||
| Q4 25 | 1.55× | 0.47× | ||
| Q3 25 | 1.52× | — | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 1.50× | — | ||
| Q4 24 | 1.34× | 0.40× | ||
| Q3 24 | 1.34× | — | ||
| Q2 24 | 1.31× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $321.2M | — |
| Free Cash FlowOCF − Capex | — | $507.0M |
| FCF MarginFCF / Revenue | — | 24.2% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $321.2M | $738.0M | ||
| Q3 25 | $26.7M | $869.5M | ||
| Q2 25 | $212.3M | $404.1M | ||
| Q1 25 | $-86.0M | $528.7M | ||
| Q4 24 | $141.7M | $722.2M | ||
| Q3 24 | $189.9M | $755.4M | ||
| Q2 24 | $90.6M | $384.1M |
| Q1 26 | — | $507.0M | ||
| Q4 25 | — | — | ||
| Q3 25 | $-44.4M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-147.4M | — | ||
| Q4 24 | $90.7M | — | ||
| Q3 24 | $146.6M | — | ||
| Q2 24 | $34.1M | — |
| Q1 26 | — | 24.2% | ||
| Q4 25 | — | — | ||
| Q3 25 | -2.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -9.0% | — | ||
| Q4 24 | 5.4% | — | ||
| Q3 24 | 9.2% | — | ||
| Q2 24 | 2.1% | — |
| Q1 26 | — | 0.5% | ||
| Q4 25 | — | — | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 3.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.72× | ||
| Q3 25 | 0.61× | 2.18× | ||
| Q2 25 | — | 1.07× | ||
| Q1 25 | -71.67× | 1.60× | ||
| Q4 24 | 14.03× | 1.56× | ||
| Q3 24 | — | 2.05× | ||
| Q2 24 | 1.25× | 1.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OLN
| Chlorinechlorinederivativesandothercoproducts | $456.2M | 27% |
| Causticsoda | $400.2M | 24% |
| Militaryandlawenforcement | $304.6M | 18% |
| Epoxyresins | $194.9M | 12% |
| Aromaticsandallylics | $164.4M | 10% |
| Commercial | $144.8M | 9% |
ROP
Segment breakdown not available.
